Metabolic checkpoints in rheumatoid arthritis.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanistic and cellular biology pathways without original human empirical data.
PubMed 39550308 · doi:10.1016/j.semarthrit.2024.152586
What was done
This narrative review summarizes current knowledge regarding the metabolic environment of the rheumatoid arthritis (RA) joint and details the cellular bioenergetic circuits that shape the pathogenic functions of RA CD4+ T cells and synovial macrophages.
What was found
No quantitative clinical or experimental metrics are reported in the abstract. Qualitatively, the review describes the RA joint as glucose-depleted and glutamine-rich. RA CD4+ T cells exhibit defective mitochondrial DNA repair, leading to suppressed mitochondrial respiration, low ATP production, reduced reactive oxygen species, and tricarboxylic acid (TCA) cycle reversal. This defect results in citrate accumulation (promoting cytoskeletal hyperacetylation and tissue invasiveness), impaired malate-aspartate shuttle activity, endoplasmic reticulum expansion leading to excessive TNF synthesis, and shunting of glucose to the pentose phosphate pathway. In contrast, RA macrophages retain active mitochondria and rely on RFX5 to upregulate HLA-DR and glutamate dehydrogenase 1 (GLUD1), driving glutaminolysis to sustain survival and antigen presentation.
Why it matters
Understanding the distinct metabolic adaptations of T cells and macrophages in the rheumatoid synovium identifies specific metabolic checkpoints that could serve as therapeutic targets for drug-resistant RA.
Limits
As a narrative review, it presents mechanistic models without systematic literature selection, formal risk-of-bias assessment, or new empirical data. The abstract provides no quantitative effect sizes or clinical outcome measurements.
Cited by
- supports Chronic immune activation results in a deficiency of intracellular NAD within immune cells.